Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder

Psychoneuroendocrinology

Volumn 33, Issue 6, 2008, Pages 773-781

  Mantella, Rose C ^a   Butters, Meryl A ^a   Amico, Janet A ^a   Mazumdar, Sati ^a,b   Rollman, Bruce L ^a   Begley, Amy E ^a   Reynolds, Charles F ^a   Lenze, Eric J ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cortisol; Elderly; Generalized anxiety disorder; HPA axis; Saliva; Worry

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVA LEVEL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SALIVA; SEVERITY OF ILLNESS INDEX;

EID: 46249123424     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.03.002     Document Type: Article

References (63)

1. Abelson J.L., and Curtis G.C. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-h secretion of corticotropin and cortisol. Arch. Gen. Psychiatry 53 (1996) 323-331
2. Altemus M., Cloitre M., and Dhabhar F.S. Enhanced cellular immune response in women with PTSD related to childhood abuse. Am. J. Psychiatry 160 (2003) 1705-1707
3. American Psychiatric Association, 2000. Dignostic and Statistical Manual of Mental Disorders, fourth ed., text revised. American Psychiatric Association, Washington, DC.
4. Avery D.H., Osgood T.B., Ishiki D.M., Wilson L.G., Kenny M., and Dunner D.L. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. Am. J. Psychiatry 142 (1985) 844-848
5. Bachmann C.G., Linthorst A.C., Holsboer F., and Reul J.M. Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis. Neuropsychopharmacology 28 (2003) 1056-1067
6. Backhaus J., Junghanns K., and Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology 29 (2004) 1184-1191
7. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K., Bruce A.B., Orth D.N., and Geracioti Jr. T.D. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 156 (1999) 585-588
8. Beekman A.T., Bremmer M.A., Deeg D.J., van Balkom A.J., Smit J.H., de Beurs E., van Dyck R., and van Tilburg W. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int. J. Geriatr. Psychiatry 13 (1998) 717-726
9. Belanoff J.K., Flores B.H., Kalezhan M., Sund B., and Schatzberg A.F. Rapid reversal of psychotic depression using mifepristone. J. Clin. Psychopharmacol. 21 (2001) 516-521
10. Belanoff J.K., Rothschild A.J., Cassidy F., DeBattista C., Baulieu E.E., Schold C., and Schatzberg A.F. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol. Psychiatry 52 (2002) 386-392
11. Bhagwagar Z., Hafizi S., and Cowen P.J. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am. J. Psychiatry 160 (2003) 1890-1891
12. Bliwise D.L. Sleep in normal aging and dementia. Sleep 16 (1993) 40-81
13. Carskadon M.A., Brown E.D., and Dement W.C. Sleep fragmentation in the elderly: relationship to daytime sleep tendency. Neurobiol. Aging 3 (1982) 321-327
14. Chaudieu I., Beluche I., Norton J., Boulenger J.P., Ritchie K., and Ancelin M.L. Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J. Affect Disord. 106 (2008) 307-313
15. Deuschle M., Gotthardt U., Schweiger U., Weber B., Korner A., Schmider J., Standhardt H., Lammers C.H., and Heuser I. With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens. Life Sci. 61 (1997) 2239-2246
16. Dratcu L., and Calil H.M. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 13 (1989) 99-117
17. Erhardt A., Ising M., Unschuld P.G., Kern N., Lucae S., Putz B., Uhr M., Binder E.B., Holsboer F., and Keck M.E. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 31 (2006) 2515-2522
18. Ferrari E., Magri F., Dori D., Migliorati G., Nescis T., Molla G., Fioravanti M., and Solerte S.B. Neuroendocrine correlates of the aging brain in humans. Neuroendocrinology 61 (1995) 464-470
19. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version: Administration Booklet (1996), American Psychiatric Press, Washington, DC
20. Flint A.J. Epidemiology and comorbidity of anxiety disorders in the elderly. Am. J. Psychiatry 151 (1994) 640-649
21. Flores B.H., Kenna H., Keller J., Solvason H.B., and Schatzberg A.F. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31 (2006) 628-636
22. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
23. Greaves-Lord K., Ferdinand R.F., Oldehinkel A.J., Sondeijker F.E., Ormel J., and Verhulst F.C. Higher cortisol awakening response in young adolescents with persistent anxiety problems. Acta Psychiatr. Scand. 116 (2007) 137-144
24. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32 (1959) 50-55
25. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
26. Heuser I., Yassouridis A., and Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28 (1994) 341-356
27. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
28. Ice G.H., Katz-Stein A., Himes J., and Kane R.L. Diurnal cycles of salivary cortisol in older adults. Psychoneuroendocrinology 29 (2004) 355-370
29. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., and Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 1085-1093
30. Jahn H., Schick M., Kiefer F., Kellner M., Yassouridis A., and Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch. Gen. Psychiatry 61 (2004) 1235-1244
31. John, D., Catherine, T., 1999. MacArthur Research Network on Socioeconomic Status and Health [Internet]. Rockefeller University: MacArthur Research Network on SES and Health; c. Salivary cortisol measurement; December 2000. Available from http://www.macses.ucsf.edu/Research/Allostatic/notebook/salivary/cort.html
32. Johnson D.A., Grant E.J., Ingram C.D., and Gartside S.E. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biol. Psychiatry (2007)
33. Kallen V.L., Tulen J.H., Utens E.M., Treffers P.D., De Jong F.H., and Ferdinand R.F. Associations between HPA axis functioning and level of anxiety in children and adolescents with an anxiety disorder. Depress. Anxiety (2007)
34. Kudielka B.M., and Kirschbaum C. Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology 28 (2003) 35-47
35. Kumar A., Alcser K., Grunhaus L., and Greden J.F. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia. Biol. Psychiatry 21 (1986) 436-444
36. Lemieux A.M., and Coe C.L. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom. Med. 57 (1995) 105-115
37. Lindley S.E., Carlson E.B., and Benoit M. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol. Psychiatry 55 (2004) 940-945
38. Lupien S., Lecours A.R., Lussier I., Schwartz G., Nair N.P., and Meaney M.J. Basal cortisol levels and cognitive deficits in human aging. J. Neurosci. 14 (1994) 2893-2903
39. Meyer T.J., Miller M.L., Metzger R.L., and Borkovec T.D. Development and validation of the Penn State Worry Questionnaire. Behav. Res. Ther. 28 (1990) 487-495
40. Miller M.D., Paradis C.F., Houck P.R., Mazumdar S., Stack J.A., Rifai A.H., Mulsant B., and Reynolds III C.F. Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale. Psychiatry Res. 41 (1992) 237-248
41. Pitman R.K., and Orr S.P. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol. Psychiatry 27 (1990) 245-247
42. Pomara N., Willoughby L.M., Sidtis J.J., Cooper T.B., and Greenblatt D.J. Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder. Psychopharmacology (Berl.) 178 (2005) 1-8
43. Pruessner J.C., Kirschbaum C., Meinlschmid G., and Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
44. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., and Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61 (1997) 2539-2549
45. Pruessner M., Hellhammer D.H., Pruessner J.C., and Lupien S.J. Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom. Med. 65 (2003) 92-99
46. Rasmusson A.M., Lipschitz D.S., Wang S., Hu S., Vojvoda D., Bremner J.D., Southwick S.M., and Charney D.S. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol. Psychiatry 50 (2001) 965-977
47. Sapolsky R.M., Krey L.C., and McEwen B.S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7 (1986) 284-301
48. Schweizer E.E., Swenson C.M., Winokur A., Rickels K., and Maislin G. The dexamethasone suppression test in generalised anxiety disorder. Br. J. Psychiatry 149 (1986) 320-322
49. Shear K., Belnap B.H., Mazumdar S., Houck P., and Rollman B.L. Generalized Anxiety Disorder Severity Scale (GADSS): a preliminary validation study. Depress. Anxiety 23 (2006) 77-82
50. Tafet G.E., Feder D.J., Abulafia D.P., and Roffman S.S. Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder. Cogn. Affect. Behav. Neurosci. 5 (2005) 37-40
51. Tiller J.W., Biddle N., Maguire K.P., and Davies B.M. The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol. Psychiatry 23 (1988) 261-270
52. Uhde T.W., Joffe R.T., Jimerson D.C., and Post R.M. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol. Psychiatry 23 (1988) 575-585
53. Urry H.L., van Reekum C.M., Johnstone T., Kalin N.H., Thurow M.E., Schaefer H.S., Jackson C.A., Frye C.J., Greischar L.L., Alexander A.L., and Davidson R.J. Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J. Neurosci. 26 (2006) 4415-4425
54. US Department of Health and Human Services. Mental Health: A Report of the Surgeon General (1999), US Deparmtnet of Health and Human Services, Rockville
55. Van Cauter E., Leproult R., and Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81 (1996) 2468-2473
56. van Coevorden A., Mockel J., Laurent E., Kerkhofs M., L'Hermite-Baleriaux M., Decoster C., Neve P., and Van Cauter E. Neuroendocrine rhythms and sleep in aging men. Am. J. Physiol. 260 (1991) E651-E661
57. Watson S., Gallagher P., Smith M.S., Ferrier I.N., and Young A.H. The dex/CRH test-is it better than the DST?. Psychoneuroendocrinology 31 (2006) 889-894
58. Wessa M., Rohleder N., Kirschbaum C., and Flor H. Altered cortisol-awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 31 (2006) 209-215
59. Wust S., Federenko I., Hellhammer D.H., and Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 25 (2000) 707-720
60. Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann. NY Acad. Sci. 1071 (2006) 137-166
61. Young E.A., Abelson J.L., and Cameron O.G. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol. Psychiatry 56 (2004) 113-120
62. Young E.A., and Breslau N. Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study. Biol. Psychiatry 56 (2004) 205-209
63. Zobel A.W., Nickel T., Kunzel H.E., Ackl N., Sonntag A., Ising M., and Holsboer F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J. Psychiatr. Res. 34 (2000) 171-181